KIT and acral lentiginous melanoma: A retrospective study (2005–2008) conducted at The University of Texas MD Anderson Cancer Center documented a 27% (46/173 cases) KIT mutation rate in primary ALM and a 14% rate (24/173 cases) in ALM metastasis [32].